Compare Gigacloud Technology Inc (GCT) vs Vaxcyte Inc. Common Stock (PCVX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Gigacloud Technology Inc vs Vaxcyte Inc. Common Stock — how do they compare? Gigacloud Technology Inc trades at $57.53 (market cap $2.04B), while Vaxcyte Inc. Common Stock trades at $67.37 (market cap $10.51B). The key difference: Vaxcyte Inc. Common Stock is far larger — about 5.2× Gigacloud Technology Inc's market cap, and Gigacloud Technology Inc is trading nearer its 52-week high, Vaxcyte Inc. Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Gigacloud Technology Inc for 20 Days and Vaxcyte Inc. Common Stock for 0 Days on average.
| GCT | PCVX | |
|---|---|---|
Market Cap | $2.04B | $10.51B |
Volume | 633,969 | 2,644,694 |
Sector | Technology | Health |
52-Week High | $57.75 | $73.82 |
52-Week Low | $25.46 | $40.32 |
Typical Hold Time | 20 Days | 0 Days |
Enterprise Value | $2.16B | $9.14B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
GCT trades at $57.03, down 1.23% today, with a bullish technical outlook from moving averages but bearish oscillators. The company demonstrates strong fundamentals with consistent earnings beats, 10.65% net margins, and robust 32.34% ROE. Recent news highlights institutional interest and analyst optimism despite insider selling activity. Revenue growth continues with 2026 projections showing $1.5B revenue and maintained profitability.
GCT presents a compelling investment case with attractive valuation multiples (P/E 13.58) and strong execution, though technical indicators show overbought conditions. Key risks include market volatility and competitive pressures, but analyst consensus remains bullish with 66.7% buy ratings and $32.50 price target suggesting significant upside potential from current levels.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Gigacloud Technology Inc
Gigacloud Technology operates a global B2B e-commerce marketplace for large-parcel goods. It provides a comprehensive solution for furniture manufacturers and retailers with integrated logistics and fulfillment.
Read more on GCT →About Vaxcyte Inc. Common Stock
Vaxcyte, Inc. is a clinical-stage vaccine company that engineers protein-based vaccines to prevent bacterial diseases such as invasive pneumococcal disease, using its proprietary cell-free protein synthesis platform to develop candidates including the pneumococcal conjugate vaccines VAX-31 and VAX-24.
Read more on PCVX →
